EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Challenges in managing endocrine and metabolic dysfunction in a child with Prader–Willi syndrome and medulloblastoma

Daniel Chan iD, Harshini Katugampola iD, Mehul T Dattani

JCEM Case Reports · 27.07.2026 · 4 (9)

DOI: 10.1210/jcemcr/luag177 ↗

Kurz gefasst

Fallbericht in der Zeitschrift JCEM Case Reports, online erschienen am 28.07.2026. Verfasst von Daniel Chan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Endocrinology, Great Ormond Street Hospital, London WC1N 3BH, UK. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prader–Willi syndrome (PWS) is a complex genetic disorder characterized by severe hyperphagia, early-onset obesity, developmental delay, behavioral disturbances, and multiple endocrine dysfunctions. Clinical management is especially challenging when complicated by central nervous system tumors, which can further exacerbate hypothalamic dysfunction with consequent endocrine and metabolic complications. We present a clinically complex case of a girl with genetically confirmed PWS who developed medulloblastoma, requiring neurosurgical resection, craniospinal radiotherapy, and chemotherapy. Subsequent management was complicated by severe obesity, insulin resistance with impaired glucose tolerance, central hypothyroidism, adrenal insufficiency, and progressive neurological decline with severe obstructive sleep apnea. Key clinical challenges highlighted include the cautious re-initiation of growth hormone therapy post-oncological treatment, carefully balancing its metabolic and growth benefits, alongside multidisciplinary strategies to manage severe obesity-related endocrine and metabolic dysfunction. This case describes the co-existence of PWS and medulloblastoma, highlighting important clinical considerations that may inform management strategies and optimize outcomes in similarly complex situations.

Schlagwörter

Stichwörter der Autor:innen

Prader–Willi syndromeendocrinopathiesgrowth hormonehypothalamic obesitymedulloblastoma

Autor:innen und Institutionen

  • Department of Pediatric Endocrinology, Great Ormond Street Hospital, London WC1N 3BH, UK.
  • Genetics and Genomic Medicine Programme, UCL Great Ormond Street Institute of Child Health, London WC1N 1EH, UK.

ORCID-Profile: Daniel Chan, Harshini Katugampola

Zitieren

APA

Chan, D., Katugampola, H., & Dattani, M. T. (2026). Challenges in managing endocrine and metabolic dysfunction in a child with Prader–Willi syndrome and medulloblastoma. JCEM Case Reports, 4(9). https://doi.org/10.1210/jcemcr/luag177

Vancouver

Chan D, Katugampola H, Dattani MT. Challenges in managing endocrine and metabolic dysfunction in a child with Prader–Willi syndrome and medulloblastoma. JCEM Case Reports. 2026;4(9). doi:10.1210/jcemcr/luag177

BibTeX
@article{Chan2026,
  author = {Chan, Daniel and Katugampola, Harshini and Dattani, Mehul T},
  title = {Challenges in managing endocrine and metabolic dysfunction in a child with Prader–Willi syndrome and medulloblastoma},
  journal = {JCEM Case Reports},
  year = {2026},
  volume = {4},
  number = {9},
  doi = {10.1210/jcemcr/luag177}
}
Kostenlos starten →